Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
Aims to become India’s leading cancer testing company
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
Metropolis Healthcare has reported total income of Rs. 309.71 crores during the period ended September 30, 2023
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
As a part of its CSR initiatives, the ‘Healthcare Heroes of India’ Awards by Metropolis aims to identify and recognize those individuals and institutions in healthcare sector with a strong sense of purpose and commitment towards patient care and who have prioritized it over all other growth parameters
The last date to apply for this program is 18th January 2022
Metropolis Healthcare has reported consolidated financial results for the period ended September 30, 2021
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.
Subscribe To Our Newsletter & Stay Updated
